Triple
T5873325
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Paediatric Regulation |
E130568
|
entity |
| Predicate | requires |
P100
|
FINISHED |
| Object | Paediatric Investigation Plan for new indications |
E130568
|
NE FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Paediatric Investigation Plan for new indications | Statement: [Paediatric Regulation, requires, Paediatric Investigation Plan for new indications]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Paediatric Investigation Plan for new indications Context triple: [Paediatric Regulation, requires, Paediatric Investigation Plan for new indications]
-
A.
Pharmacovigilance Risk Assessment Committee within the European Medicines Agency
The Pharmacovigilance Risk Assessment Committee within the European Medicines Agency is an expert body responsible for evaluating and monitoring the safety of medicines across the European Union and providing recommendations on managing and communicating medicine-related risks.
-
B.
Conditional Marketing Authorization by European Medicines Agency
Conditional Marketing Authorization by the European Medicines Agency is a fast-track regulatory pathway that allows earlier approval of medicines, such as COVID-19 vaccines, based on less comprehensive data than normally required, provided that the benefits outweigh the risks and additional data will be supplied post-approval.
-
C.
Paediatric Regulation
chosen
The Paediatric Regulation is a European Union law designed to improve the development and availability of medicines specifically adapted for use in children.
-
D.
Certificates of Suitability to the monographs of the European Pharmacopoeia
Certificates of Suitability to the monographs of the European Pharmacopoeia are official documents issued by the European Directorate for the Quality of Medicines & HealthCare (EDQM) confirming that a substance’s quality complies with the relevant European Pharmacopoeia monograph, thereby simplifying regulatory approval for medicines across Europe.
-
E.
Clinical Practices of the University of Pennsylvania
Clinical Practices of the University of Pennsylvania is the faculty practice plan and outpatient clinical arm of Penn Medicine, providing patient care across a wide range of specialties in collaboration with the University of Pennsylvania’s health system.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69c0085047dc8190af24e311edad3c07 |
completed | March 22, 2026, 3:18 p.m. |
| NER | Named-entity recognition | batch_69c035f99b788190b5b06d83b9499bfa |
completed | March 22, 2026, 6:33 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69c0b11b48d88190ba6cd5ade2f47a89 |
completed | March 23, 2026, 3:18 a.m. |
Created at: March 22, 2026, 3:57 p.m.